Abstract Background and Aims Up to 14% of upper gastrointestinal cancer (UGIC) subjects
underwent esophago-gastro-duodenoscopy (EGD) in the preceding 3 years, which did not …

Background & aims Ten percent of patients with an upper gastrointestinal cancer will have
received an esophagogastroduodenoscopy (EGD) within 3 years before diagnosis, termed …

Background A significant proportion of upper gastrointestinal cancers (UGICs) remain
undetected during esophagogastroduodenoscopy (EGD). We investigated the …

OBJECTIVES: Little is known about missed rates of upper gastrointestinal cancer (UGC) in
Western populations, with most data originating from Japanese centers quoting high missed …

Background Missing upper gastrointestinal cancer (UGIC) at endoscopy may prevent
curative treatment. We have developed a root cause analysis system for potentially missed …

Introduction Meta-analysis of published literature suggests that up to 14% of upper
gastrointestinal cancer (UGIC) subjects had a negative oesophagogastroduodenoscopy …

Objectives Data on the long-term survival outcome of patients with missed upper
gastrointestinal cancers (MUGC) is lacking. Retrospective studies have found no difference …

Introduction Meta-analysis of published single hospital series including 1977 subjects
suggests that 14% of gastric cancer (GC) subjects have had an upper gastrointestinal …

Introduction The frequency of upper gastrointestinal cancer being diagnosed following a
negative oesophagogastroduodenoscopy (OGD) up to 3 years previously in selected single …

Abstract Background and Aims: In the United States, little is known about the rates of interval
upper gastrointestinal (GI) cancer (possibly missed out) after an …